Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Vivek P. Chavda, Melina Haritopoulou-Sinanidou, Rajashri Bezbaruah & Vasso Apostolopoulos. (2022) Vaccination efforts for Buruli ulcer. Expert Review of Vaccines 21:10, pages 1419-1428.
Read now
Read now
Yonghui Liu, Zhaoyu Wang, Fan Yu, Mingjing Li, Haomiao Zhu, Kun Wang, Meng Meng & Wei Zhao. (2021) The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines. International Journal of Nanomedicine 16, pages 403-420.
Read now
Read now
Stephen E Wright. (2012) Immunotherapy of breast cancer. Expert Opinion on Biological Therapy 12:4, pages 479-490.
Read now
Read now
Pamela E Constantinou, Brian P Danysh, Neeraja Dharmaraj & Daniel D Carson. (2011) Transmembrane mucins as novel therapeutic targets. Expert Review of Endocrinology & Metabolism 6:6, pages 835-848.
Read now
Read now
Silvia von Mensdorff-Pouilly. (2010) Vaccine-induced antibody responses in patients with carcinoma. Expert Review of Vaccines 9:6, pages 579-594.
Read now
Read now
Choon-Kit Tang & Vasso Apostolopoulos. (2008) Strategies used for MUC1 immunotherapy: preclinical studies. Expert Review of Vaccines 7:7, pages 951-962.
Read now
Read now
Articles from other publishers (56)
Luigi Buonaguro & Maria Tagliamonte. (2023) Peptide-based vaccine for cancer therapies. Frontiers in Immunology 14.
Crossref
Crossref
Yicong Wang, Lifeng Liu & Yongai Yu. (2023) Mucins and mucinous ovarian carcinoma: Development, differential diagnosis, and treatment. Heliyon 9:8, pages e19221.
Crossref
Crossref
Jing-Jing Du, Shi-Hao Zhou, Zi-Ru Cheng, Wen-Bo Xu, Ru-Yan Zhang, Long-Sheng Wang & Jun Guo. (2022) MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide. Frontiers in Chemistry 10.
Crossref
Crossref
Ayusha Dondulkar, Natasha Akojwar, Chanti Katta, Dharmendra K. Khatri, Neelesh K. Mehra, Shashi B. Singh & Jitender Madan. (2022) Inhalable Polymeric Micro and Nano-immunoadjuvants for Developing Therapeutic
Vaccines in the Treatment of Non-small Cell Lung Cancer. Current Pharmaceutical Design 28:5, pages 395-409.
Crossref
Crossref
Nicolas Jonckheere, Audrey Vincent, Bernadette Neve & Isabelle Van Seuningen. (2021) Mucin expression, epigenetic regulation and patient survival: A toolkit of prognostic biomarkers in epithelial cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876:1, pages 188538.
Crossref
Crossref
Nor Adzimah Johdi & Nur Fazilah Sukor. (2020) Colorectal Cancer Immunotherapy: Options and Strategies. Frontiers in Immunology 11.
Crossref
Crossref
Bo Sun, Feifei Xu, Yuanyuan Zhang, Yechen Hu & Yun Chen. (2020)
Dual-Probe Approach for Mass Spectrometric Quantification of MUC1-Specific Terminal Gal/GalNAc
In Situ
. Analytical Chemistry 92:12, pages 8340-8349.
Crossref
Crossref
Jing-Jing Du, Chang-Wei Wang, Wen-Bo Xu, Lian Zhang, Yuan-Kai Tang, Shi-Hao Zhou, Xiao-Fei Gao, Guang-Fu Yang & Jun Guo. (2020) Multifunctional Protein Conjugates with Built-in Adjuvant (Adjuvant-Protein-Antigen) as Cancer Vaccines Boost Potent Immune Responses. iScience 23:3, pages 100935.
Crossref
Crossref
Vanessa Barriga, Nyanbol Kuol, Kulmira Nurgali & Vasso Apostolopoulos. (2019) The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer. Cancers 11:8, pages 1205.
Crossref
Crossref
Vasso Apostolopoulos. (2019) Cancer Vaccines: Research and Applications. Cancers 11:8, pages 1041.
Crossref
Crossref
Hye-Youn Son, Vasso Apostolopoulos & Chul-Woo Kim. (2017) Mannosylated T/Tn with Freund’s adjuvant induces cellular immunity. International Journal of Immunopathology and Pharmacology 31, pages 039463201774250.
Crossref
Crossref
Yan Tang, Xiuxia Cui, Han Xiao, Shengkun Qi, Xiaoping Hu, Qiong Yu, Guang Shi, Xue Zhang, Jiaying Gu, Yongli Yu, Liying Wang & Yarong Li. (2017) Binding of circulating anti-MUC1 antibody and serum MUC1 antigen in stage IV breast cancer. Molecular Medicine Reports.
Crossref
Crossref
Juan Wang, Wei-hua Ni, Ke-bang Hu, Xiao-yu Zhai, Fei Xie, Jing Jie, Nan-nan Zhang, Li-na Jiang, Hong-yan Yuan & Gui-xiang Tai. (2017) Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma. Cancer Science 108:3, pages 504-511.
Crossref
Crossref
Silvia von Mensdorff-Pouilly. 2017. Encyclopedia of Cancer. Encyclopedia of Cancer
657
668
.
Olivera Finn & Lixin Zhang. 2017. Cancer Therapeutic Targets. Cancer Therapeutic Targets
391
398
.
W. Fiedler, S. DeDosso, S. Cresta, J. Weidmann, A. Tessari, M. Salzberg, B. Dietrich, H. Baumeister, S. Goletz, L. Gianni & C. Sessa. (2016) A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas. European Journal of Cancer 63, pages 55-63.
Crossref
Crossref
Haihong Zhang, Chenlu Liu, Fangfang Zhang, Fei Geng, Qiu Xia, Zhenzhen Lu, Ping Xu, Yu Xie, Hui Wu, Bin Yu, Jiaxin Wu, Xianghui Yu & Wei Kong. (2016) MUC1 and survivin combination tumor gene vaccine generates specific immune responses and anti-tumor effects in a murine melanoma model. Vaccine 34:24, pages 2648-2655.
Crossref
Crossref
Boqi Hu, Juan Wang, Yingying Guo, Tanxiu Chen, Weihua Ni, Hongyan Yuan, Nannan Zhang, Fei Xie & Guixiang Tai. (2016) Pre-clinical toxicity and immunogenicity evaluation of a MUC1–MBP/BCG anti-tumor vaccine. International Immunopharmacology 33, pages 108-118.
Crossref
Crossref
Fengtao You, Licui Jiang, Bozhen Zhang, Qiang Lu, Qiao Zhou, Xiaoyang Liao, Hong Wu, Kaiqi Du, Youcai Zhu, Huimin Meng, Zhishu Gong, Yunhui Zong, Lei Huang, Man Lu, Jirong Tang, Yafen Li, Xiaochen Zhai, Xiangling Wang, Sisi Ye, Dan Chen, Lei Yuan, Lin Qi & Lin Yang. (2016) Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells. Science China Life Sciences 59:4, pages 386-397.
Crossref
Crossref
Vasso Apostolopoulos, Lily Stojanovska & Sharron E. Gargosky. (2015) MUC1 (CD227): a multi-tasked molecule. Cellular and Molecular Life Sciences 72:23, pages 4475-4500.
Crossref
Crossref
Abdelfattah Attallah, Mohamed El-Far, Camelia Abdel Malak, Khaled Farid, Mohamed Omran, Raida Yahya, Entsar Saad, Mohamed Albannan, Ahmed Attallah, Mohamed El Basuni, Islam Ali, Safaa Abed & Mohamed El Naggar. (2015) A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma. Annals of Hepatology 14:6, pages 869-880.
Crossref
Crossref
Krishna Pillai, Mohammad H. Pourgholami, Terence C. Chua & David L. Morris. (2015) MUC1 as a Potential Target in Anticancer Therapies. American Journal of Clinical Oncology 38:1, pages 108-118.
Crossref
Crossref
Ryan Stevenson, Martin Goodman & Muhammad Wasif Saif. 2015. Cancer Immunology. Cancer Immunology
237
248
.
Tsukasa Tanida, Masahiro Tanemura, Eiji Miyoshi, Hiroaki Nagano, Kenta Furukawa, Yuji Nonaka, Hirofumi Akita, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, Shogo Kobayashi, Hidetoshi Eguchi, Masaki Mori & Yuichiro Doki. (2014) Pancreatic cancer immunotherapy using a tumor lysate vaccine, engineered to express α-gal epitopes, targets pancreatic cancer stem cells. International Journal of Oncology.
Crossref
Crossref
Nicolas Jonckheere, Nicolas Skrypek & Isabelle Van Seuningen. (2014) Mucins and tumor resistance to chemotherapeutic drugs. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:1, pages 142-151.
Crossref
Crossref
Riva Kovjazin, Galit Horn, Nechama I. Smorodinsky, Michael Y. Shapira & Lior Carmon. (2014) Cell Surface-Associated Anti-MUC1-Derived Signal Peptide Antibodies: Implications for Cancer Diagnostics and Therapy. PLoS ONE 9:1, pages e85400.
Crossref
Crossref
David M. McDonald, Brendan L. Wilkinson, Leo Corcilius, Morten Thaysen-Andersen, Scott N. Byrne & Richard J. Payne. (2014) Synthesis and immunological evaluation of self-adjuvanting MUC1-macrophage activating lipopeptide 2 conjugate vaccine candidates. Chem. Commun. 50:71, pages 10273-10276.
Crossref
Crossref
Silvia von Mensdorff-Pouilly. 2014. Encyclopedia of Cancer. Encyclopedia of Cancer
1
12
.
Xianling Cong. (2013) Antitumor effect of adenoviral vector prime protein boost immunity targeting the MUC1 VNTRs. Oncology Reports.
Crossref
Crossref
Michael A. Morse, Donna Niedzwiecki, John L. Marshall, Christopher Garrett, David Z. Chang, Mebea Aklilu, Todd S. Crocenzi, David J. Cole, Sophie Dessureault, Amy C. Hobeika, Takuya Osada, Mark Onaitis, Bryan M. Clary, David Hsu, Gayathri R. Devi, Anuradha Bulusu, Robert P. Annechiarico, Vijaya Chadaram, Timothy M. Clay & H. Kim Lyerly. (2013) A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer. Annals of Surgery 258:6, pages 879-886.
Crossref
Crossref
Stamatis VassilarosAnastasios Tsibanis, Annivas Tsikkinis, Geoffrey A Pietersz, Ian FC McKenzie & Vasso Apostolopoulos. (2013) Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan–MUC1. Immunotherapy 5:11, pages 1177-1182.
Crossref
Crossref
Nicolas Jonckheere, Nicolas Skrypek, Frédéric Frénois & Isabelle Van Seuningen. (2013) Membrane-bound mucin modular domains: From structure to function. Biochimie 95:6, pages 1077-1086.
Crossref
Crossref
Takashi Kimura, John R. McKolanis, Lynda A. Dzubinski, Kazi Islam, Douglas M. Potter, Andres M. Salazar, Robert E. Schoen & Olivera J. Finn. (2013) MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study. Cancer Prevention Research 6:1, pages 18-26.
Crossref
Crossref
Elena Niccolai, Domenico Prisco, Mario Milco D'Elios & Amedeo Amedei. (2013) What Is Recent in Pancreatic Cancer Immunotherapy?. BioMed Research International 2013, pages 1-14.
Crossref
Crossref
Olivera Finn & Lixin Zhang. 2016. Cancer Therapeutic Targets. Cancer Therapeutic Targets
1
8
.
Yu-Qian Wang, Hai-Hong Zhang, Chen-Lu Liu, Qiu Xia, Hui Wu, Xiang-Hui Yu & Wei Kong. (2012) Correlation Between Auto-antibodies to Survivin and MUC1 Variable Number Tandem Repeats in Colorectal Cancer. Asian Pacific Journal of Cancer Prevention 13:11, pages 5557-5562.
Crossref
Crossref
Tharappel C. James & Ursula Bond. (2012) Molecular Mimics of the Tumour Antigen MUC1. PLoS ONE 7:11, pages e49728.
Crossref
Crossref
RIVA KOVJAZIN, ANNA DUBNIK, GALIT HORN, NECHAMA I. SMORODINSKY, IZHAR HARDAN, MICHAEL YECHIEL SHAPIRA & LIOR CARMON. (2012) Autoantibodies against the signal peptide domain of MUC1 in patients with multiple myeloma: Implications for disease diagnosis and prognosis. Experimental and Therapeutic Medicine 3:6, pages 1092-1098.
Crossref
Crossref
Neelima R. Mehta, Gregory T. Wurz, Rebekah A. Burich, Brittany E. Greenberg, Stephen Griffey, Audrey Gutierrez, Katie E. Bell, Jamie L. McCall, Michael Wolf & Michael DeGregorio. (2012) L-BLP25 Vaccine plus Letrozole Induces a TH1 Immune Response and Has Additive Antitumor Activity in MUC1-Expressing Mammary Tumors in Mice. Clinical Cancer Research 18:10, pages 2861-2871.
Crossref
Crossref
Jiang Chen, Hong-Yu Li, Di Wang, Jia-Jun Zhao & Xiao-Zhong Guo. (2011) Human dendritic cells transfected with amplified MUC1 mRNA stimulate cytotoxic T lymphocyte responses against pancreatic cancer in vitro. Journal of Gastroenterology and Hepatology 26:10, pages 1509-1518.
Crossref
Crossref
Silvia Von Mensdorff-Pouilly, Maria Moreno & René H. M. Verheijen. (2011) Natural and Induced Humoral Responses to MUC1. Cancers 3:3, pages 3073-3103.
Crossref
Crossref
Athanassios Stavrakoudis, Ioannis G. Tsoulos, Katalin Uray, Ferenc Hudecz & Vasso Apostolopoulos. (2010) Homology modeling and molecular dynamics simulations of MUC1-9/H-2Kb complex suggest novel binding interactions. Journal of Molecular Modeling 17:7, pages 1817-1829.
Crossref
Crossref
Lindzy F Dodson, William G Hawkins & Peter Goedegebuure. (2011) Potential targets for pancreatic cancer immunotherapeutics. Immunotherapy 3:4, pages 517-537.
Crossref
Crossref
Shigeo Koido, Sadamu Homma, Akitaka Takahara, Yoshihisa Namiki, Shintaro Tsukinaga, Jimi Mitobe, Shunichi Odahara, Toyokazu Yukawa, Hiroshi Matsudaira, Keisuke Nagatsuma, Kan Uchiyama, Kenichi Satoh, Masaki Ito, Hideo Komita, Hiroshi Arakawa, Toshifumi Ohkusa, Jianlin Gong & Hisao Tajiri. (2011) Current Immunotherapeutic Approaches in Pancreatic Cancer. Clinical and Developmental Immunology 2011, pages 1-15.
Crossref
Crossref
Lubor Borsig. 2011. Glycans in Diseases and Therapeutics. Glycans in Diseases and Therapeutics
63
81
.
Silvia von Mensdorff-Pouilly. 2011. Encyclopedia of Cancer. Encyclopedia of Cancer
514
521
.
Min Li, Lujun Song & Xinyu Qin. (2010) Glycan changes: cancer metastasis and anti-cancer vaccines. Journal of Biosciences 35:4, pages 665-673.
Crossref
Crossref
Nicolas Jonckheere, Nicolas Skrypek & Isabelle Van Seuningen. (2010) Mucins and Pancreatic Cancer. Cancers 2:4, pages 1794-1812.
Crossref
Crossref
Fu-ling Zhou, Shan Meng, Wang-gang Zhang, Yong-chang Wei, Xing-mei Cao, Gai-gai Bai & Bai-yan Wang. (2010) Peptide-based immunotherapy for multiple myeloma: Current approaches. Vaccine 28:37, pages 5939-5946.
Crossref
Crossref
Daniel E. Speiser & Pedro Romero. (2010) Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity. Seminars in Immunology 22:3, pages 144-154.
Crossref
Crossref
Richard E Beatson, Joyce Taylor-Papadimitriou & Joy M Burchell. (2010) MUC1 immunotherapy. Immunotherapy 2:3, pages 305-327.
Crossref
Crossref
Nicolas Jonckheere & Isabelle Van Seuningen. (2010) The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers. Biochimie 92:1, pages 1-11.
Crossref
Crossref
H Yang, N-H Cho & S-Y Seong. (2009) The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours. Clinical and Experimental Immunology 158:2, pages 174-185.
Crossref
Crossref
S Julien, G Picco, R Sewell, A-S Vercoutter-Edouart, M Tarp, D Miles, H Clausen, J Taylor-Papadimitriou & J M Burchell. (2009) Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model. British Journal of Cancer 100:11, pages 1746-1754.
Crossref
Crossref
Ena WangAdriana Albini, David F StroncekFrancesco M Marincola. (2009) New take on comparative immunology: relevance to immunotherapy. Immunotherapy 1:3, pages 355-366.
Crossref
Crossref
Shigeo Koido, Eiichi Hara, Sadamu Homma, Yoshihisa Namiki, Toshifumi Ohkusa, Jianlin Gong & Hisao Tajiri. (2009) Cancer Vaccine by Fusions of Dendritic and Cancer Cells. Clinical and Developmental Immunology 2009, pages 1-13.
Crossref
Crossref